Archives: Agenda

Compared to traditional pharmaceutical companies, the development and advancement of clinical pipelines employ significantly different strategies and methodologies. In response to the international R&D and clinical environment, targeted clinical development planning is required, with distinct operational priorities and practices.

• Artificial Intelligence Accelerates Global Drug Development Planning.
• Global Clinical Trial Strategy and
• Best Practices for Efficient Global Drug
• Packaging Strategies and Protocols for Clinical

英矽智能是全球领先的 AI 驱动生物科技公司，专注于 利用人工智能技术加速药物研发。和传统药企相比，临 床管线的开发和推进有着非常不同的策略和方法。针对 国际化的研发和临床环境，需要针对性的临床研发布 局，在运作层面也有不同的重点和实践

• 人工智能加速全球药物研发布局
• 全球临床试验策略和布局
• 全球高效药品供应的最佳实践
• 针对临床方案的包装策略和方案

• Challenges in Clinical Drug Supply
• Application of New Technologies in Clinical Drug Supply Management.
• Global Case Studies and

• 临床药物供应管理的挑战
• 临床药物供应管理的新技术应用
• 全球案例分享与探讨。

• Interpretation of Policies on Cross-Border Data Transfer in the Pharmaceutical Industry
• Analysis of the Negative List Policy in the Pharmaceutical Industry
• Sharing Compliance Practices for Cross-Border Data Transfer in the Pharmaceutical Industry

• 医药行业数据出境政策解读
• 医药行业负面清单政策解读
• 医药行业数据出境合规实践分享

• Updates on China’s National Medical Products Administration (NMPA)
• Recent reforms in drug and device approval
• Best practices for obtaining IND and NDA approvals in China

• 中国国家药品监督管理局（NMPA）法规更新
• 药品和医疗器械审批流程的最新改革
• 在中国获得 IND（新药临床试验申请）和 NDA（新药上市申请）批准的最佳实践

• Forecasting and planning: Using predictive analytics for accurate demand forecasting and minimizing supply shortages.
• Risk management strategies: Identifying and mitigating risks.
• Building contingency plans to address disruptions in the supply chain, from production delays to shipping issues.
• Direct-to-patient shipping: Managing risks and benefits of shipping clinical trial products directly to patients in remote areas.

• 中国供应链地位的提升：从区域支持到全球枢纽
• 国际药企供应链重心转移的机遇与挑战
• 双循环模式下的协同创新：国内大循环支撑国际外循环
• 风险对冲：地缘政治与自主可控能力建设

• Choosing the right vendors: Best practices for selecting CMOs (Contract Manufacturing Organizations), logistics providers, and technology suppliers
• Building and maintaining strong vendor relationships: How to foster long-term, collaborative partnerships in China
• Criteria for evaluating vendor capabilities in compliance, quality, and local expertise
• Navigating vendor selection challenges in China for clinical trial supply

• 优选供应商策略：CMO（合同生产组织）、物流服务商与技术供应商的遴选标准
• 建立可持续的合作关系：中国本土长期协作伙伴培养之道
• 供应商能力评估维度：合规性、质量体系与本地化专业能力
• 中国临床试验供应链供应商选择的特殊挑战